Mishelle R Seiler is a pharmacist who is specialized in Psychiatric in Plano, Texas. Patients can reach her at 8720 Country Glen Xing, Plano or contact her on 972-377-6965. Active license number of Mishelle R Seiler is 39453 for Psychiatric in Texas. Mishelle R Seiler is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Mishelle R Seiler speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mishelle R Seiler
Specialization:
Psychiatric
Credentials:
PHARM.D., BCPP
Gender:
Female
Location:
8720 Country Glen Xing, Plano, Texas, 75024-3780
Phone:
972-377-6965
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mishelle R Seiler are as mentioned below.
NPI Number:
1740281716
NPI Enumeration Date:
02 Aug, 2005
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mishelle R Seiler are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
39453
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8720 Country Glen Xing, Plano, Texas
Zip:
75024-3780
Phone Number:
972-377-6965
Fax Number:
--
Patients can reach Mishelle R Seiler at 8720 Country Glen Xing, Plano, Texas or can call on phone at 972-377-6965.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.